HER2 Support Group Forums - View Single Post - Medicare facing cancer, cardiac care cuts

Rich66 · 11-11-2009, 04:19 PM

Ugggg..
http://weisenthalcancer.com/Professi...surancepro.htm
"Medical Insurance Coverage Insurance coverage for Functional Tumor Cell Profiling varies depending upon the reimbursement policies of the patient's insurance carrier and the provisions of his or her specific insurance policy. Many insurance carriers cover most or all of the testing fees, excluding normal co-payments and deductible amounts. However, other insurance carriers pay for only a portion of the costs and some carriers may deny claims completely. Patients will be billed for any co-payments, deductible amounts, or other balances that are not paid by the patient's carrier. As a courtesy to your patient, we gladly will submit insurance claims to the carrier before requesting payment from the patient. We will also assist in appealing an unfavorable coverage decision in the event that an insurance claim is denied. Our collections policy is liberal and humane. We always allow ample time for insurance claims work their way through the system, including carrier information requests and appeals when necessary

Effective July 1, 2008, Weisenthal Cancer Group elected voluntarily to opt-out as a Medicare provider owing to excessive delays in receiving payments and also due to Medicare's erratic coverage patterns, despite the fact that an exhaustive technology review by Medicare resulted in what was supposed to have been routine coverage for Medicare beneficiaries for functional tumor cell profiling beginning in February of 2007. We regret that Medicare's slow and inconsistent payment policies along with its lack of responsiveness to our inquiries necessitated this action on our part. This does NOT mean that we do not perform testing for Medicare beneficiaries. We offer our testing services equally to all patients. However, it means that Medicare beneficiaries assume financial responsibility for their testing services in the same manner as non-Medicare beneficiaries. "

11-11-2009, 04:19 PM	#9
Rich66 Senior Member Join Date: Feb 2008 Location: South East Wisconsin Posts: 3,431	Re: Medicare facing cancer, cardiac care cuts Ugggg.. http://weisenthalcancer.com/Professi...surancepro.htm "Medical Insurance Coverage Insurance coverage for Functional Tumor Cell Profiling varies depending upon the reimbursement policies of the patient's insurance carrier and the provisions of his or her specific insurance policy. Many insurance carriers cover most or all of the testing fees, excluding normal co-payments and deductible amounts. However, other insurance carriers pay for only a portion of the costs and some carriers may deny claims completely. Patients will be billed for any co-payments, deductible amounts, or other balances that are not paid by the patient's carrier. As a courtesy to your patient, we gladly will submit insurance claims to the carrier before requesting payment from the patient. We will also assist in appealing an unfavorable coverage decision in the event that an insurance claim is denied. Our collections policy is liberal and humane. We always allow ample time for insurance claims work their way through the system, including carrier information requests and appeals when necessary Effective July 1, 2008, Weisenthal Cancer Group elected voluntarily to opt-out as a Medicare provider owing to excessive delays in receiving payments and also due to Medicare's erratic coverage patterns, despite the fact that an exhaustive technology review by Medicare resulted in what was supposed to have been routine coverage for Medicare beneficiaries for functional tumor cell profiling beginning in February of 2007. We regret that Medicare's slow and inconsistent payment policies along with its lack of responsiveness to our inquiries necessitated this action on our part. This does NOT mean that we do not perform testing for Medicare beneficiaries. We offer our testing services equally to all patients. However, it means that Medicare beneficiaries assume financial responsibility for their testing services in the same manner as non-Medicare beneficiaries. " __________________ Mom's treatment history (link)